Literature DB >> 28759817

Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure.

Waqas Hanif1, Linda Alex1, Ya Su1, Arti V Shinde1, Ilaria Russo1, Na Li1, Nikolaos G Frangogiannis2.   

Abstract

Left ventricular dysfunction increases left atrial pressures and causes atrial remodeling. In human subjects, increased left atrial size is a powerful predictor of mortality and adverse events in a broad range of cardiac pathologic conditions. Moreover, structural remodeling of the atrium plays an important role in the pathogenesis of atrial tachyarrhythmias. Despite the potential value of the atrium in assessment of functional endpoints in myocardial disease, atrial pathologic alterations in mouse models of left ventricular disease have not been systematically investigated. Our study describes the geometric, morphologic, and structural changes in experimental mouse models of cardiac pressure overload (induced through transverse aortic constriction), myocardial infarction, and diabetes. Morphometric and histological analysis showed that pressure overload was associated with left atrial dilation, increased left atrial mass, loss of myofibrillar content in a subset of atrial cardiomyocytes, atrial cardiomyocyte hypertrophy, and atrial fibrosis. In mice undergoing nonreperfused myocardial infarction protocols, marked left ventricular systolic dysfunction was associated with left atrial enlargement, atrial cardiomyocyte hypertrophy, and atrial fibrosis. Both infarcted animals and pressure overloaded mice exhibited attenuation and perturbed localization of atrial connexin-43 immunoreactivity, suggesting gap junctional remodeling. In the absence of injury, obese diabetic db/db mice had diastolic dysfunction associated with atrial dilation, atrial cardiomyocyte hypertrophy, and mild atrial fibrosis. Considering the challenges in assessment of clinically relevant functional endpoints in mouse models of heart disease, study of atrial geometry and morphology may serve as an important new tool for evaluation of ventricular function.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial remodeling; Diabetes; Fibrosis; Heart failure; Hypertrophy; Myocardial infarction

Mesh:

Substances:

Year:  2017        PMID: 28759817      PMCID: PMC5592139          DOI: 10.1016/j.carpath.2017.06.003

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  49 in total

Review 1.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

2.  Utility of preload alteration in assessment of left ventricular filling pressure by Doppler echocardiography: a simultaneous catheterization and Doppler echocardiographic study.

Authors:  D G Hurrell; R A Nishimura; D M Ilstrup; C P Appleton
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

3.  Effects of diabetes mellitus on left atrial volume and functions in normotensive patients without symptomatic cardiovascular disease.

Authors:  Halil Atas; Alper Kepez; Dilek Barutcu Atas; Batur Gonenc Kanar; Ramile Dervisova; Tarik Kivrak; Mustafa Kursat Tigen
Journal:  J Diabetes Complications       Date:  2014-07-30       Impact factor: 2.852

4.  Wheat germ agglutinin staining as a suitable method for detection and quantification of fibrosis in cardiac tissue after myocardial infarction.

Authors:  B Emde; A Heinen; A Gödecke; K Bottermann
Journal:  Eur J Histochem       Date:  2014-12-17       Impact factor: 3.188

Review 5.  Atrial fibrillation from the pathologist's perspective.

Authors:  Domenico Corradi
Journal:  Cardiovasc Pathol       Date:  2013-12-15       Impact factor: 2.185

6.  Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats.

Authors:  Shotaro Saito; Yasushi Teshima; Akira Fukui; Hidekazu Kondo; Satoru Nishio; Mikiko Nakagawa; Tetsunori Saikawa; Naohiko Takahashi
Journal:  Cardiovasc Res       Date:  2014-07-31       Impact factor: 10.787

7.  Long-term prognostic significance of left atrial volume in acute myocardial infarction.

Authors:  Roy Beinart; Valentina Boyko; Ehud Schwammenthal; Rafael Kuperstein; Alex Sagie; Hanoch Hod; Shlomo Matetzky; Solomon Behar; Michael Eldar; Micha S Feinberg
Journal:  J Am Coll Cardiol       Date:  2004-07-21       Impact factor: 24.094

8.  Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy.

Authors:  Woo-In Yang; Chi Young Shim; Young Jin Kim; Sung-Ai Kim; Sang Jae Rhee; Eui-Young Choi; Donghoon Choi; Yangsoo Jang; Namsik Chung; Seung-Yun Cho; Jong-Won Ha
Journal:  J Am Soc Echocardiogr       Date:  2009-10-30       Impact factor: 5.251

9.  Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload.

Authors:  Ying Xia; Keunsang Lee; Na Li; Daniel Corbett; Leonardo Mendoza; Nikolaos G Frangogiannis
Journal:  Histochem Cell Biol       Date:  2008-11-22       Impact factor: 4.304

10.  Structural correlate of atrial fibrillation in human patients.

Authors:  Sawa Kostin; Gabi Klein; Zoltan Szalay; Stefan Hein; Erwin P Bauer; Jutta Schaper
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more
  19 in total

1.  Detection of Myocardial Fibrosis and Left Ventricular Dysfunction with Cardiac MRI in a Hypertensive Swine Model.

Authors:  Baiyan Zhuang; Chen Cui; Arlene Sirajuddin; Jian He; Xin Wang; Guangxin Yue; Xuejing Duan; Hongyue Wang; Andrew E Arai; Shihua Zhao; Minjie Lu
Journal:  Radiol Cardiothorac Imaging       Date:  2020-08-27

Review 2.  PI3K(p110α) as a determinant and gene therapy for atrial enlargement in atrial fibrillation.

Authors:  Martin Ezeani; Sandeep Prabhu
Journal:  Mol Cell Biochem       Date:  2022-07-28       Impact factor: 3.842

3.  Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways.

Authors:  Bin-Cheng Ren; Yu-Fei Zhang; Shan-Shan Liu; Xiao-Jing Cheng; Xin Yang; Xiao-Guang Cui; Xin-Rui Zhao; Hui Zhao; Min-Feng Hao; Meng-Dan Li; Yuan-Yuan Tie; Li Qu; Xue-Yi Li
Journal:  J Cell Mol Med       Date:  2020-09-22       Impact factor: 5.310

4.  Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.

Authors:  Linda Alex; Ilaria Russo; Volodymir Holoborodko; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-13       Impact factor: 4.733

5.  Trypanosoma cruzi Neurotrophic Factor Facilitates Cardiac Repair in a Mouse Model of Chronic Chagas Disease.

Authors:  Tamar Ledoux; Daniel Aridgides; Ryan Salvador; Njabulo Ngwenyama; Smaro Panagiotidou; Pilar Alcaide; Robert M Blanton; Mercio A Perrin
Journal:  J Pharmacol Exp Ther       Date:  2018-10-22       Impact factor: 4.030

6.  [Changes of two-pore K+ channel TASK-1 in diabetic myocardial injury in rats].

Authors:  Heng Zhang; Min Tao; Pinfang Kang; Jianlu Guo; Ling Xuan; Bi Tang; Qin Gao; Hongju Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

Review 7.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

8.  A multicenter study comparing the outcome of catheter ablation of atrial fibrillation between cryoballoon and radiofrequency ablation in patients with heart failure (CRABL-HF): Study design.

Authors:  Koji Miyamoto; Kanae Hasegawa; Hiroki Takahashi; Yoh Masue; Naoya Kataoka; Koji Fukuzawa; Keiichi Ashikaga; Takashi Noda; Kazuhiro Satomi; Hiroshi Tada; Masahiko Takagi; Satoshi Yasuda; Kengo Kusano
Journal:  J Arrhythm       Date:  2020-03-15

9.  Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling.

Authors:  Naoko Yamaguchi; Junhua Xiao; Deven Narke; Devin Shaheen; Xianming Lin; Erik Offerman; Alireza Khodadadi-Jamayran; Akshay Shekhar; Alex Choy; Sojin Y Wass; David R Van Wagoner; Mina K Chung; David S Park
Journal:  Circulation       Date:  2020-11-23       Impact factor: 29.690

Review 10.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.